SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-158432
Filing Date
2019-05-28
Accepted
2019-05-28 17:00:59
Documents
4
Period of Report
2019-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d731510d8k.htm 8-K 20418
2 EX-10.1 d731510dex101.htm EX-10.1 101892
3 EX-10.2 d731510dex102.htm EX-10.2 55109
4 EX-10.3 d731510dex103.htm EX-10.3 46556
  Complete submission text file 0001193125-19-158432.txt   225025
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 19858507
SIC: 2834 Pharmaceutical Preparations